Cart
sales@molnova.com
IL-15-IN-1
CAS No. 1831830-20-6
IL-15-IN-1( —— )
Catalog No. M23831 CAS No. 1831830-20-6
IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 209 | In Stock |
|
| 5MG | 164 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 25MG | 429 | In Stock |
|
| 50MG | 591 | In Stock |
|
| 100MG | 798 | In Stock |
|
| 200MG | 1070 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIL-15-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionIL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
-
DescriptionIL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorIL-15
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1831830-20-6
-
Formula Weight576.71
-
Molecular FormulaC30H36N6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:122 mg/mL (211.55 mM; Need ultrasonic)
-
SMILESO=C(OCC)C1=CC=CC(NC(CCCCCCCSC2=NN=C(CC3=NN(C)C(C4=C3C=CC=C4)=O)N2C)=O)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Quéméner A, et al. Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization. J Med Chem. 2017 Jul 27;60(14):6249-6272.
molnova catalog
related products
-
Ganoderic acid A
Ganoderic acid A exhibits antitumor activity, mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1.
-
Siltuximab
Siltuximab（CNTO-328） is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.
-
GSK717
GSK717 is a potent and selective inhibitor of nucleotide-binding oligomerization domain 2 (NOD2). GSK717 blocks synergy between NOD2 and TLR2. GSK717 does not affect NOD1, TNFR1 and TLR2-mediated responses.
